Vaccination for COVID19 infection is in full swing all around the world and while the vaccines are considered overall safe, many cutaneous and extracutaneous adverse effects have been reported after their use. Local injection-site reactions are the commonest adverse effect described with the use of these vaccines. We describe a case of Sweet syndrome in an elderly female after the first dose of Oxford-AstraZeneca COVID-19 vaccine (AZD1222).
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8646808 | PMC |
| http://dx.doi.org/10.1111/dth.15146 | DOI Listing |
Publication Analysis
Top Keywords
sweet syndrome
8
oxford-astrazeneca covid-19
8
covid-19 vaccine
8
vaccine azd1222
8
elderly female
8
syndrome oxford-astrazeneca
4
azd1222 elderly
4
female vaccination
4
vaccination covid19
4
covid19 infection
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!